{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:27:14Z","timestamp":1778830034035,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005857","name":"Uniwersytet Przyrodniczy w Poznaniu","doi-asserted-by":"publisher","award":["508-86-00-0"],"award-info":[{"award-number":["508-86-00-0"]}],"id":[{"id":"10.13039\/501100005857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Trivalent chromium (Cr) and bitter melon (<jats:italic>Momordica charantia<\/jats:italic> L., BM) have been shown to independently interact with the insulin signaling pathway leading to improvements in the symptoms of insulin resistance and diabetes in some animal models and human subjects. The aim of this study was to examine whether the combination of the two nutritional supplements could potentially have additive effects on treating these conditions in high-fat-fed streptozotocin (STZ)-induced diabetic rats. The experiment was conducted with 110 male Wistar rats divided into eleven groups and fed either a control or high-fat diet for 7\u00a0weeks. Half of the rats on the high-fat diet were injected with STZ (30\u00a0mg\/kg body mass) to induce diabetes. The high-fat (HF) diets were then supplemented with a combination of Cr (as chromium(III) propionate complex, Cr3: either 10 or 50\u00a0mg Cr\/kg diet) and bitter melon (lyophilized whole fruit: either 10 or 50\u00a0g\/kg diet) for 6\u00a0weeks. After termination of the experiment, blood and internal organs were harvested for blood biochemical, hematological, and mineral (Cr) analyses using appropriate analytical methods. It was found that neither Cr(III) nor BM was able to significantly affect blood indices in HF and diabetic rats, but BM tended to improve body mass gain, blood glucose, and LDL cholesterol values, but decreased Cr content in the liver and kidneys of the Cr-co-supplemented type 2 diabetic model of rats. Supplementary Cr(III) had no appreciable effect on glucose and lipid metabolism in high-fat-fed STZ-induced diabetic rats. Supplementary BM fruit powder had some observable effects on body mass of high-fat-fed rats; these effects seem to be dampened when BM was co-administered with Cr. Cr(III) and BM appear to act as nutritional antagonists when both administered in food, probably due to binding of Cr by the polyphenol-type compounds present in the plant material.<\/jats:p>","DOI":"10.1007\/s12011-020-02202-y","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T16:06:59Z","timestamp":1591114019000},"page":"1013-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Bitter Melon and a Chromium Propionate Complex on Symptoms of Insulin Resistance and Type 2 Diabetes in Rat Models"],"prefix":"10.1007","volume":"199","author":[{"given":"Pandora E.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Kr\u00f3l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Szwengiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Tubacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Szczepankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Staniek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-7459","authenticated-orcid":false,"given":"Zbigniew","family":"Krejpcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"2202_CR1","volume-title":"The bioinorganic chemistry of chromium","author":"JB Vincent","year":"2013","unstructured":"Vincent JB (2013) The bioinorganic chemistry of chromium. Wiley, Chichester"},{"key":"2202_CR2","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1002\/anie.200460113","volume":"43","author":"I Mulkani","year":"2004","unstructured":"Mulkani I, Levina A, Lay PA (2004) Biomimetic oxidation of chromium(III): does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)? Angew Chem Int Ed 43:4504\u20134507","journal-title":"Angew Chem Int Ed"},{"key":"2202_CR3","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/S0277-5387(99)00166-7","volume":"18","author":"JK Speetjens","year":"1999","unstructured":"Speetjens JK, Parand A, Crowder MW, Vincent JB (1999) Low-molecular-weight chromium-binding substance and biomimetic [Cr3O(O2CH2CH3)6(H2O)3]+ do not cleave DNA under physiologically-relevant conditions. Polyhedron 18:2617\u20132624","journal-title":"Polyhedron"},{"key":"2202_CR4","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0277-5387(01)00822-1","volume":"20","author":"AA Shute","year":"2001","unstructured":"Shute AA, Vincent JB (2001) The stability of the biomimetic cation triaqua-\u03bc-xohexapropionatotrichromium(III) in vivo in rats. Polyhedron 20:2241\u20132252","journal-title":"Polyhedron"},{"key":"2202_CR5","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1021\/ic970568h","volume":"36","author":"CM Davis","year":"1997","unstructured":"Davis CM, Royer AC, Vincent JB (1997) Synthetic multinuclear chromium assembly activates insulin receptor tyrosine kinase activity: functional model for low-molecular-weight chromium-binding substance. Inorg Chem 36:5316\u20135320","journal-title":"Inorg Chem"},{"key":"2202_CR6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1385\/BTER:98:2:159","volume":"98","author":"BJ Clodfelder","year":"2004","unstructured":"Clodfelder BJ, Chang C, Vincent JB (2004) Absorption of the biomimetic cation triqua-\u03bc3-oxo-\u03bc-hexapropionatotrichromium(III) in rats. Biol Trace Elem Res 98:522\u2013533","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bdrb.20140","volume":"83","author":"MM Bailey","year":"2008","unstructured":"Bailey MM, Sturdivant J, Jernigan PL, Townsend MB, Bushman J, Ankareddi I, Rasco JF, Hood RD, Vincent JB (2008) Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium picolinate and [Cr3O(O2CH2CH3)6(H2O)3]+, in mice. Birth Defects Res Develop Reprod Toxicol 83:27\u201331","journal-title":"Birth Defects Res Develop Reprod Toxicol"},{"key":"2202_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1385\/BTER:113:1:53","volume":"113","author":"R Bennett","year":"2006","unstructured":"Bennett R, Adams B, French A, Neggers Y, Vincent JB (2006) High-dose chromium(III) supplementation has no effects on body mass and composition while altering plasma hormone and triglycerides concentrations. Biol Trace Elem Res 113:53\u201366","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00775-004-0618-0","volume":"10","author":"BJ Clodfelder","year":"2005","unstructured":"Clodfelder BJ, Gullick BM, Lukaski HC, Neggers Y, Vincent JB (2005) Oral administration of [Cr3O(O2CH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem 10:119\u2013130","journal-title":"J Biol Inorg Chem"},{"key":"2202_CR10","first-page":"206","volume":"17","author":"B Debski","year":"2004","unstructured":"Debski B, Krejpcio Z, Kuryl T, Wojciak R, Lipko M (2004) Biomimetic chromium(III) complex and fructan supplementation affect insulin and membrane glucose transport in rats. J Trace Elem Exp Med 17:206\u2013207","journal-title":"J Trace Elem Exp Med"},{"key":"2202_CR11","first-page":"207","volume":"17","author":"Z Krejpcio","year":"2004","unstructured":"Krejpcio Z, Debski B, Wojciak R, Kuryl T, Tubacka M (2004) Biomimetic chromium(III) complex and fructan supplementation improve blood variables in STZ-induced diabetic rats. J Trace Elem Exp Med 17:207\u2013208","journal-title":"J Trace Elem Exp Med"},{"key":"2202_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/BTER:114:1:237","volume":"114","author":"T Kuryl","year":"2006","unstructured":"Kuryl T, Krejpcio Z, Wojciak R, Lipko M, Debski B, Staniek H (2006) Chromium(III) propionate and dietary fructans supplementation stimulate erythrocyte glucose uptake and betaoxidation in lymphocytes of rats. Biol Trace Elem Res 114:237\u2013248","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jinorgbio.2004.03.018","volume":"98","author":"A Pickering","year":"2004","unstructured":"Pickering A, Chang C, Vincent JB (2004) Chromium-containing biomimetic cation triaqua-\u03bc3-hexapropionatotrichromium(III) inhibits colorectal tumor formation in rats. J Inorg Biochem 98:1303\u20131306","journal-title":"J Inorg Biochem"},{"key":"2202_CR14","first-page":"852","volume":"7","author":"Y Sun","year":"2002","unstructured":"Sun Y, Clodfelder BJ, Shute AA, Irvin T, Vincent JB (2002) The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Inorg Biochem 7:852\u2013862","journal-title":"J Inorg Biochem"},{"key":"2202_CR15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s007750050357","volume":"4","author":"Y Sun","year":"1999","unstructured":"Sun Y, Mallya K, Ramirez J, Vincent JB (1999) The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics. J Biol Inorg Chem 4:838\u2013845","journal-title":"J Biol Inorg Chem"},{"key":"2202_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1874104501105010070","volume":"5","author":"J Singh","year":"2011","unstructured":"Singh J, Cumming E, Manoharan G, Kalasz H, Adeghate E (2011) Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions. Open Med Chem J 5:70\u201377","journal-title":"Open Med Chem J"},{"key":"2202_CR17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/bmj.282.6279.1823","volume":"282","author":"BA Leatherdale","year":"1981","unstructured":"Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH (1981) Improvement in glucose tolerance due to Momordica charantia (karela). Brit Med J (Clinical Research Edition) 282:1823\u20131824","journal-title":"Brit Med J (Clinical Research Edition)"},{"key":"2202_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.scienta.2014.07.024","volume":"182","author":"C Han","year":"2015","unstructured":"Han C, Zuo J, Wang Q, Xu L, Wang Z, Dong H, Gao L (2015) Effects of 1-MCP on postharvest physiology and quality of bitter melon (Momordica charantia L.). Sci Hortic 182:86\u201391","journal-title":"Sci Hortic"},{"key":"2202_CR19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/food.19930370210","volume":"37","author":"K Platel","year":"1993","unstructured":"Platel K, Shurpalekar KS, Srinivasan K (1993) Influence of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats. Nahrung 37:156\u2013160","journal-title":"Nahrung"},{"key":"2202_CR20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/np50018a002","volume":"44","author":"P Khanna","year":"1981","unstructured":"Khanna P, Jain SC, Panagariya A, Dixit VP (1981) Hypoglycemic activity of polypeptide-p from a plant source. J Natural Products 44:648\u2013655","journal-title":"J Natural Products"},{"key":"2202_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pathophys.2018.05.003","volume":"25","author":"OO Elekofehinti","year":"2018","unstructured":"Elekofehinti OO, Ariyo EO, Akinjiyan MO, Olayerijua SO, Lawal AO, Adanlawob IG, Teixeira Rocha JB (2018) Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: in silico and in vivo studies. Pathophysiol 25:327\u2013333","journal-title":"Pathophysiol"},{"key":"2202_CR22","doi-asserted-by":"crossref","unstructured":"Earnshaw A, Figgis BN, Lewis J (1966) Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates. J Chem Society A:1656\u20131663","DOI":"10.1039\/j19660001656"},{"issue":"2","key":"2202_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12011-013-9877-3","volume":"157","author":"E Kr\u00f3l","year":"2014","unstructured":"Kr\u00f3l E, Krejpcio Z, Iwanik K (2014) Supplementary chromium(III) propionate complex does not protect against insulin resistance in high-fat-fed rats. Biol Trace Elem Res 157(2):147\u2013155","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.fct.2010.07.008","volume":"48","author":"E Kr\u00f3l","year":"2010","unstructured":"Kr\u00f3l E, Krejpcio Z (2010) Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem Toxicol 48:2791\u20132796","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"2202_CR25","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.fct.2011.09.006","volume":"49","author":"E Kr\u00f3l","year":"2011","unstructured":"Kr\u00f3l E, Krejpcio Z (2011) Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem Toxicol 49(12):3217\u20133223","journal-title":"Food Chem Toxicol"},{"key":"2202_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12011-012-9515-5","volume":"150","author":"E Kr\u00f3l","year":"2012","unstructured":"Kr\u00f3l E, Krejpcio Z, Michalak S, Wojciak RW, Bogdanski P (2012) Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats. Biol Trace Elem Res 150:350\u2013359","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"2202_CR27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12906-017-1833-x","volume":"17","author":"DY Saad","year":"2017","unstructured":"Saad DY, Soliman MM, Baiomy AA, Yassin MH, El-Sawy HB (2017) Effects of karela (bitter melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study. BMC Complement Altern Med 17(1):319","journal-title":"BMC Complement Altern Med"},{"key":"2202_CR28","first-page":"179","volume":"14","author":"R Abas","year":"2015","unstructured":"Abas R, Othman F, Thent ZC (2015) Effect of Momordica charantia fruit extract on vascular complication in type 1 diabetic rats. EXCLI J 14:179\u2013189","journal-title":"EXCLI J"},{"issue":"3","key":"2202_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jnutbio.2014.10.010","volume":"26","author":"SJ Yang","year":"2015","unstructured":"Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY (2015) Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-\u03baB and JNK pathways in high-fat-fed OLETF rats. J Nutr Biochem 26(3):234\u2013240","journal-title":"J Nutr Biochem"},{"key":"2202_CR30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jn\/132.6.1107","volume":"132","author":"WT Cefalu","year":"2002","unstructured":"Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132:1107\u20131114","journal-title":"J Nutr"},{"key":"2202_CR31","first-page":"398","volume":"45","author":"M Yukata","year":"1999","unstructured":"Yukata M (1999) A homogeneous assay for the selective measurement of LDL cholesterol in serum. Enzymatic selective protection method. Clin Lab 45:398\u2013401","journal-title":"Clin Lab"},{"key":"2202_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/clinchem\/36.2.325","volume":"36","author":"MD Shephard","year":"1990","unstructured":"Shephard MD, Whiting MJ (1990) Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder\u2019s chromogen. Clin Chem 36:325\u2013329","journal-title":"Clin Chem"},{"key":"2202_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-8981(02)00341-8","volume":"327","author":"G Schumann","year":"2003","unstructured":"Schumann G, Klauke R (2003) New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 327:69\u201379","journal-title":"Clin Chim Acta"},{"key":"2202_CR34","unstructured":"Thomas L (1998) Total protein. In Thomas L (Ed.), Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. TH-Books Verlagsgesellschaft, FrankfuntMain 644-647"},{"key":"2202_CR35","unstructured":"Newmann DJ, Price CP (1999) Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER (Eds.). Tietz book of clinical chemistry (3rd ed.). WB Saunders Company, Philadelphia 1239\u20131242"},{"key":"2202_CR36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/2359-3997000000169","volume":"60","author":"LC Antunes","year":"2016","unstructured":"Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC (2016) Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrin Metab 60:138\u2013142","journal-title":"Arch Endocrin Metab"},{"key":"2202_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12011-017-0985-3","volume":"180","author":"H Staniek","year":"2017","unstructured":"Staniek H, Krejpcio Z (2017) The effects of supplementary Cr3 (chromium(III) propionate complex) on the mineral status in healthy female rats. Biol Trace Elem Res 180:90\u201399","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.fct.2009.12.022","volume":"48","author":"H Staniek","year":"2010","unstructured":"Staniek H, Krejpcio Z, Iwanik K (2010) Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat. Food Chem Toxicol 48:859\u2013864","journal-title":"Food Chem Toxicol"},{"key":"2202_CR39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12011-015-0518-x","volume":"171","author":"H Staniek","year":"2016","unstructured":"Staniek H, Krejpcio Z, Wieczorek D (2016) The effects of high dietary doses of chromium(III) complex with propionic acid on nutritional and selected blood indices in healthy female rats. Biol Trace Elem Res 171:192\u2013200","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"2202_CR40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12011-012-9565-8","volume":"151","author":"H Staniek","year":"2013","unstructured":"Staniek H, Rhodes NR, Di Bona KR, Deng G, Love ST, Pledger LA, Blount J, Gomberg E, Grappe F, Cernosek C, Peoples B, Rasco JF, Krejpcio Z, Vincent JB (2013) Comparison of tissue metal concentrations in zucker lean, zucker obese, and zucker diabetic fatty rats and the effects of chromium supplementation on tissue metal concentrations. Biol Trace Elem Res 151(3):373\u2013383","journal-title":"Biol Trace Elem Res"},{"key":"2202_CR41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jnutbio.2010.09.004","volume":"22","author":"ZQ Wang","year":"2011","unstructured":"Wang ZQ, Zhang XH, Yu Y, Poulev A, Ribnicky D, Floyd ZE, Cefalu WT (2011) Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem 22:1064\u20131073","journal-title":"J Nutr Biochem"},{"key":"2202_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.12717\/DR.2017.21.3.259","volume":"21","author":"NA Yoon","year":"2017","unstructured":"Yoon NA, Park J, Lee J, Jeong JY, Kim H-K, Lee HS, Hwang IG, Roh GS, Kim HJ, Cho GJ, Choi WS, Lee DH, Kang SS (2017) Anti-diabetic effects of ethanol extract from bitter melon in mice fed a high-fat diet. Develop Reprod 21:259\u2013267","journal-title":"Develop Reprod"},{"key":"2202_CR43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jnutbio.2014.10.010","volume":"26","author":"SJ Yang","year":"2015","unstructured":"Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WJ, Oh KW, Park SW, Park CY (2015) Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-\u03ba\u03b2 and JNK pathways in high-fat-fed OLETF rats. J Nutr Biochem 26:234\u2013240","journal-title":"J Nutr Biochem"},{"key":"2202_CR44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1017\/S000711450783176X","volume":"99","author":"MG Sridhar","year":"2008","unstructured":"Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N (2008) Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Brit J Nutr 99:806\u2013812","journal-title":"Brit J Nutr"},{"key":"2202_CR45","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/fsn3.706","volume":"6","author":"W-C Bong","year":"2018","unstructured":"Bong W-C, Savage G (2018) Oxalate content of raw, wok-fried, and juice made from bitter gourd fruits. Food Sci Nutr 6:2015\u20132019","journal-title":"Food Sci Nutr"},{"key":"2202_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-4238(02)00154-1","volume":"97","author":"Y Kawazu","year":"2003","unstructured":"Kawazu Y, Okimura M, Ishii T, Yui S (2003) Varietal and seasonal differences in oxalate content of spinach. Sci Hortic 97:203\u2013210","journal-title":"Sci Hortic"},{"key":"2202_CR47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/qjmed\/hcq239","volume":"104","author":"L Mascitelli","year":"2010","unstructured":"Mascitelli L, Goldstein MR (2010) Inhibition of iron absorption by polyphenols as an anti-cancer mechanism. QJM 104:459\u2013461","journal-title":"QJM"},{"issue":"2","key":"2202_CR48","first-page":"347","volume":"3","author":"P Mackowiak","year":"2010","unstructured":"Mackowiak P, Krejpcio Z, Sassek M, Kaczmarek P, Hertig I, Chmielewska J, Wojciechowicz T, Szczepankiewicz D, Wieczorek D, Szymusiak H, Nowak KW (2010) Evaluation of insulin binding and signaling activity of newly synthesized chromium(III) complexes in vitro. Mol Med Rep 3(2):347\u2013353","journal-title":"Mol Med Rep"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-020-02202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-020-02202-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-020-02202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:39:39Z","timestamp":1622594379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-020-02202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2202"],"URL":"https:\/\/doi.org\/10.1007\/s12011-020-02202-y","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted and were approved by the IACUC\u2019s of The University of Alabama and Pozna\u0144 University of Life Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statements"}},{"value":"The authors declare that they have no conflict of interest. J.B.V. is the inventor or co-inventor of 6 patents involving the synthesis or use of Cr3 or its derivatives as nutritional supplements or therapeutic agents. The patents are owned by The University of Alabama, which is neither currently licensing the patents nor selling Cr3.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}